HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
QTRX
Quanterix Corporation
QTRX lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
QTRX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Under pressure | |
| Unavailable |
QTRX's revenue is currently stable, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
QTRX PE Valuation
QTRX has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
QTRX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect QTRX's losses to shrink, with revenue holding steady. However, they disagree widely on these estimates.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has the edge over QTRX on earnings, with more consistent year-over-year improvement.
QTRX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.35 | -$0.02 |
| Q2 2026 | -$2.62 | -$0.80 |
| Q1 2026 | -$2.35 | -$1.11 |
| Q4 2025 | -$2.51 | -$1.51 |
| Q3 2025 | -$2.33 | -$1.40 |
| Q2 2025 | -$1.82 | -$0.90 |
| Q1 2025 | -$1.24 | -$0.35 |
| Q4 2024 | -$1.00 | -$0.24 |
QTRX lost $2.35 per share over the past year, about the same as its loss the year before.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over QTRX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over QTRX on profitability, with a higher operating margin.
QTRX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $35M | -13% |
| Q2 2026 | $32.9M | +34% |
| Q1 2026 | $36.4M | +20% |
| Q4 2025 | $43.9M | +25% |
| Q3 2025 | $40.2M | +12% |
| Q2 2025 | $24.5M | -29% |
| Q1 2025 | $30.3M | -5.4% |
| Q4 2024 | $35.2M | +11% |
QTRX's revenue is growing: $35M last quarter, down 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -64% | +29 points |
| Q2 2026 | -150% | +1.4 points |
| Q1 2026 | -114% | -27 points |
| Q4 2025 | -56% | -14 points |
| Q3 2025 | -93% | -60 points |
| Q2 2025 | -152% | -120 points |
| Q1 2025 | -87% | -40 points |
| Q4 2024 | -42% | +1.2 points |
QTRX's operating margin was −64% last quarter, up 28 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over QTRX on cash generation, producing positive trailing cash flow while its opponent burns cash.
QTRX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$16.3M | +$25.6M |
| Q2 2026 | -$5.2M | +$1.2M |
| Q1 2026 | -$18.2M | -$3.1M |
| Q4 2025 | -$16.3M | -$11.6M |
| Q3 2025 | -$41.9M | -$35.3M |
| Q2 2025 | -$6.4M | +$118K |
| Q1 2025 | -$15.1M | +$5.5M |
| Q4 2024 | -$4.7M | +$3.4M |
QTRX has burned cash in almost every quarter: −$56M over the past year, against −$68M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over QTRX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
QTRX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +221K shares |
| 1 year | +2.9% | +1.3M shares |
| 3 years | +26% | +9.7M shares |
| 5 years | +30% | +10.9M shares |
| Available history | +69% | +19.4M shares |
QTRX has 47M diluted shares, up 2.9% from a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
QTRX Net Leverage
QTRX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
QTRX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.1 | Neutral |
| Stochastic | 39.4 | Neutral |
QTRX's weekly RSI is 43 (neutral) and its Stochastic is 39 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
QTRX PE vs Healthcare Sector
QTRX has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
QTRX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.07 | 6.8% below |
| 20 week MA | $3.22 | 11% below |
| 50 week MA | $4.24 | 33% below |
| 100 week MA | $5.37 | 47% below |
| 200 week MA | $11.9 | 76% below |
QTRX is in a downtrend: it's below all five of its weekly moving averages, and 76% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over QTRX on returns for 2026, with the stronger performance.
QTRX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.5 | $45.9 | +95% |
| 2021 | $45.9 | $43.9 | -4.5% |
| 2022 | $43.9 | $12.9 | -71% |
| 2023 | $12.9 | $27.3 | +112% |
| 2024 | $27.3 | $11.1 | -60% |
| 2025 | $11.1 | $6.46 | -42% |
| 2026 YTD | $6.46 | $2.86 | -56% |
QTRX's yearly returns have swung widely, from +112% in 2023 to −71% in 2022. It's down 56% so far in 2026.